melbourne presentation, page-10

Totally agree with what was said.

To add to that, If a successful and meaningful GH reduction using ATL1103 with no safety issue on healthy individual, it may have a huge market. Imwould benthe first to inject myself on the way to longevity!

While the influx of cheap shares and free oppies is holding down the SP due to the supply from the CR, away from this there are quite a few people working on some important deals : ATL 1103 Phase II trial design, ATL1102 JV details, ATL 1101 funding negotiation and I assume that the Pharma doing the DD on ATL1103 is still sitting on the fence waiting for a direction from their management.

It is a ticking time bomb waiting to be exploded once the CR dust is settlled and all the weak hands are shown.

I predict the SP will be back to high 2s and mid 3s before the end of May without news. If we have good news, the sky is the limit.


JIMO DYOR